Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.
- DOI
- 10.1111/1759-7714.15319
- Published
- 2024 Jun
- Container
- Thoracic cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/1759-7714.15319,
title = {Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.},
author = {Shigeta N and Murakami S and Yokose T and Isaka T and Shinada K and Nagashima T and Adachi H and Shigefuku S and Murakami K and Miura J and Kikunishi N and Watabe K and Saito H and Ito H},
year = {2024},
journal = {Thoracic cancer},
doi = {10.1111/1759-7714.15319},
url = {https://doi.org/10.1111/1759-7714.15319}
}RIS
TY - JOUR TI - Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer. AU - Shigeta N AU - Murakami S AU - Yokose T AU - Isaka T AU - Shinada K AU - Nagashima T AU - Adachi H AU - Shigefuku S AU - Murakami K AU - Miura J AU - Kikunishi N AU - Watabe K AU - Saito H AU - Ito H PY - 2024 JO - Thoracic cancer DO - 10.1111/1759-7714.15319 UR - https://doi.org/10.1111/1759-7714.15319 ER -
APA
N, S., S, M., T, Y., T, I., K, S., T, N., H, A., S, S., K, M., J, M., N, K., K, W., H, S., & H, I. (2024). Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.. Thoracic cancer. https://doi.org/10.1111/1759-7714.15319
Source records
- pubmed · retrieved 2026-09-26T08:32:46.392Z